<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: The differential diagnosis between idiopathic and <z:hpo ids='HP_0001638'>cardiomyopathy</z:hpo>-related right ventricular outflow tract (RVOT) <z:hpo ids='HP_0004308'>ventricular arrhythmias</z:hpo> (VAs) is crucial </plain></SENT>
<SENT sid="1" pm="."><plain>Signal-averaged ECG (SAECG) abnormalities are frequent in <z:hpo ids='HP_0001638'>cardiomyopathy</z:hpo>-related RVOT-VAs, although their pathophysiologic basis and diagnostic value in this setting are undefined </plain></SENT>
<SENT sid="2" pm="."><plain>We tested the association between SAECG and the myocardial substrate underlying RVOT-VAs </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS AND RESULTS: Twenty-four consecutive patients (median age, 50 years [42-59]; 12 men) with RVOT-VAs (10 with frequent [&gt;1000/24 hours] <z:hpo ids='HP_0006682'>premature ventricular contractions</z:hpo>, 14 with <z:hpo ids='HP_0004756'>ventricular tachycardias</z:hpo>) underwent SAECG with 40-Hz filtering and electroanatomic mapping (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">EAM</z:e>) with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">EAM</z:e>-guided biopsy for characterization of the RVOT-VAs substrate </plain></SENT>
<SENT sid="4" pm="."><plain>A filtered averaged QRS (<z:mp ids='MP_0010514'>fQRS</z:mp>) was obtained and analyzed for <z:mp ids='MP_0010514'>fQRS</z:mp> duration, low amplitude signal duration&lt;40 mV (LAS40), and root-mean-square voltage in the last 40 ms of the QRS (RMS40) </plain></SENT>
<SENT sid="5" pm="."><plain>Standard definition of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">EAM</z:e> scar was used </plain></SENT>
<SENT sid="6" pm="."><plain><z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">EAM</z:e>-guided biopsy diagnosed ARVC in 11 (46%), <z:mp ids='MP_0001856'>myocarditis</z:mp> in 8 (33%), and idiopathic RVOT-VAs in 5 (21%) patients </plain></SENT>
<SENT sid="7" pm="."><plain>Patients with <z:hpo ids='HP_0001638'>cardiomyopathy</z:hpo>-related RVOT-VAs had ≥1 EAM scar (median, 2 [1-2]; <z:hpo ids='HP_0000001'>all</z:hpo> with RVOT scar) </plain></SENT>
<SENT sid="8" pm="."><plain><z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">EAM</z:e> of patients with idiopathic RVOT-VAs was <z:mpath ids='MPATH_458'>normal</z:mpath> </plain></SENT>
<SENT sid="9" pm="."><plain>Patients with <z:hpo ids='HP_0001638'>cardiomyopathy</z:hpo>-related RVOT-VAs had significantly longer <z:mp ids='MP_0010514'>fQRS</z:mp> (106 ms [92-132] versus 83 ms [82-84], P=0.01) and LAS40 (39 ms [36-51] versus 19 ms [18-21], P=0.02), and lower RMS40 (18 µV [9-26] versus 33 µV [32-33], P=0.04) </plain></SENT>
<SENT sid="10" pm="."><plain>A significant linear correlation was found between the extension (cm2) of the RVOT scar and <z:hpo ids='HP_0000001'>all</z:hpo> 3 SAECG parameters (rs=0.76, P&lt;0.001 for the fQRSd; rs=0.73, P&lt;0.001 for the LAS40; and rs=-0.72, P&lt;0.001 for the RMS40) </plain></SENT>
<SENT sid="11" pm="."><plain>Using the established 2 of 3 criteria (ie, late potentials), SAECG diagnosed <z:hpo ids='HP_0001638'>cardiomyopathy</z:hpo>-related RVOT-VAs with high positive (100%) but low negative (38%) predictive values and missed 7 of 9 (78%) patients with RVOT scar&lt;8 cm2 </plain></SENT>
<SENT sid="12" pm="."><plain>CONCLUSIONS: In patients with RVOT-VAs, abnormal SAECG parameters reflect the presence of extensive cardiomyopathic involvement of the RVOT </plain></SENT>
<SENT sid="13" pm="."><plain>However, a negative SAECG does not reliably rule out <z:hpo ids='HP_0001638'>cardiomyopathy</z:hpo>-related RVOT-VAs in the presence of a small RVOT scar </plain></SENT>
</text></document>